Back to search

PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies

Data up to Jan 2025

Published2013
Citations790
References38

Total Citations Per Year

Abstract

References (38)

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

2012 • 11,574 citations

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

2012 • 7,361 citations

Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation

2000 • 4,853 citations

PD-1 and Its Ligands in Tolerance and Immunity

2008 • 4,838 citations

Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion

2002 • 4,625 citations

Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape

2012 • 1,988 citations

Inhibitory B7-family molecules in the tumour microenvironment

2008 • 1,511 citations

Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma

2010 • 1,218 citations

Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma

2010 • 1,193 citations

Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus

1996 • 1,175 citations

The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma

2003 • 843 citations

Plasmablastic Lymphomas of the Oral Cavity: A New Entity Associated With the Human Immunodeficiency Virus Infection

1997 • 823 citations

Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma

2013 • 721 citations

Nonnasal Lymphoma Expressing the Natural Killer Cell Marker CD56: A Clinicopathologic Study of 49 Cases of an Uncommon Aggressive Neoplasm

1997 • 665 citations

Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)

2008 • 658 citations

Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy

2012 • 631 citations

SPECTRUM OF EPSTEIN-BARR VIRUS–ASSOCIATED DISEASES

2006 • 483 citations

Age-Related EBV-Associated B-Cell Lymphoproliferative Disorders Constitute a Distinct Clinicopathologic Group: A Study of 96 Patients

2007 • 435 citations

Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells.

1991 • 415 citations

Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity?

1998 • 362 citations

The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma

2007 • 319 citations

Programmed Death Ligand 1 Is Expressed by Non–Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells

2011 • 314 citations

Epstein–Barr Virus-Negative Post-Transplant Lymphoproliferative Disorders

2000 • 302 citations

B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders

2009 • 209 citations

Analysis and interpretation of data

2014 • 208 citations

Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial

2012 • 203 citations

Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma

2010 • 186 citations

Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.

1993 • 182 citations

Serum CD163 and TARC as Disease Response Biomarkers in Classical Hodgkin Lymphoma

2012 • 100 citations

Lymphomas differ in their dependence on Epstein-Barr virus

2010 • 87 citations

Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico.

1998 • 80 citations

The Role of Epstein-Barr Virus in Neoplastic Transformation

2001 • 79 citations

Refined Prognostic Role of CD68-Positive Tumor Macrophages in the Context of the Cellular Micromilieu of Classical Hodgkin Lymphoma

2010 • 78 citations

Figure 3, A.

2008 • 69 citations

Shades of gray between large B-cell lymphomas and Hodgkin lymphomas: differential diagnosis and biological implications

2013 • 63 citations

Infectious agents in human cancers: Lessons in immunity and immunomodulation from gammaherpesviruses EBV and KSHV

2011 • 51 citations

Locally advanced nasopharyngeal carcinoma: Current and emerging treatment strategies

2011 • 39 citations

Prognostic role of tumor-associated macrophages and angiogenesis in classical Hodgkin lymphoma

2013 • 27 citations

Cited By (0)

No citing papers found in database

PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and… (2013) – Clinical Cancer Research | Metascience Observatory Explorer